• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥氮平口崩片与标准奥氮平片相比在急性治疗的精神科患者中的有效性及药物接受度

Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients.

作者信息

Czekalla Jörg, Wagner Thomas, Schacht Alexander, Kluge Michael, Kinon Bruce

机构信息

Department of Psychiatry and Psychotherapy, RWTH Aachen University, Germany;

出版信息

Patient Prefer Adherence. 2007 Dec 20;1:19-27. doi: 10.2147/ppa.s2300.

DOI:10.2147/ppa.s2300
PMID:19956444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2779125/
Abstract

BACKGROUND

This study compared effectiveness and acceptance of orally disintegrating olanzapine tablets (ODT) with standard-coated tablets (SOT) in acutely ill psychiatric patients admitted to psychiatric hospitals for emergency treatment.

METHODS

Large, prospective, observational study at hospital emergency units across Germany in patients with a diagnosis or tentative diagnosis of acute schizophrenia treated with ODT or SOT. Clinical (CGI-S and CGI-I) outcomes, attitudes towards medication (Nursing Assessment of Medication Acceptance, NAMA) scale, suicidal ideation, and adverse events were assessed at start of treatment and after 2 weeks.

RESULTS

Both olanzapine formulations, ODT (N = 247) and SOT (N = 207), showed similar effectiveness after 2 weeks. CGI-I improved in 92.1% of patients (ODT: 91.8%, SOT: 92.3%). In patients receiving both formulations suicidal ideations were reduced (ODT from 53.9% to 20.6%, SOT from 51.2% to 22.7%). ODT was preferably given to severely ill (SOT: 49.8%, ODT: 64.4%) and aggressive patients. Adverse events were reported for 6.5% of ODT- and 2.9% of SOT-patients. This difference was possibly caused by the characteristics of patients receiving ODT.

CONCLUSIONS

This non-randomized, observational study shows comparable outcomes and tolerability in patients treated with both olanzapine formulations. In an acute treatment setting, orally disintegrating tablets were preferably used for more severely ill and aggressive patients with low medication acceptance.

摘要

背景

本研究比较了口腔崩解型奥氮平片(ODT)与标准包衣片(SOT)在因紧急治疗而入住精神病医院的急性病精神病患者中的有效性和可接受性。

方法

在德国各地医院急诊科对诊断或初步诊断为急性精神分裂症且接受ODT或SOT治疗的患者进行大型前瞻性观察性研究。在治疗开始时和2周后评估临床(CGI-S和CGI-I)结果、对药物的态度(药物接受度护理评估,NAMA)量表、自杀意念和不良事件。

结果

两种奥氮平制剂,ODT(N = 247)和SOT(N = 207),在2周后显示出相似的有效性。92.1%的患者CGI-I有所改善(ODT:91.8%,SOT:92.3%)。接受两种制剂的患者自杀意念均有所降低(ODT从53.9%降至20.6%,SOT从51.2%降至22.7%)。ODT更常用于重症患者(SOT:49.8%,ODT:64.4%)和有攻击性的患者。报告ODT患者中有6.5%发生不良事件,SOT患者中有2.9%发生不良事件。这种差异可能是由接受ODT治疗的患者特征所致。

结论

这项非随机观察性研究表明,两种奥氮平制剂治疗的患者结果和耐受性相当。在急性治疗环境中,口腔崩解片更适合用于病情更严重、有攻击性且药物接受度低的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9497/2779125/70533fad24fe/ppa-1-019f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9497/2779125/f30afec8fab7/ppa-1-019f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9497/2779125/c8b95e484e3e/ppa-1-019f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9497/2779125/70533fad24fe/ppa-1-019f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9497/2779125/f30afec8fab7/ppa-1-019f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9497/2779125/c8b95e484e3e/ppa-1-019f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9497/2779125/70533fad24fe/ppa-1-019f3.jpg

相似文献

1
Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients.奥氮平口崩片与标准奥氮平片相比在急性治疗的精神科患者中的有效性及药物接受度
Patient Prefer Adherence. 2007 Dec 20;1:19-27. doi: 10.2147/ppa.s2300.
2
Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States.几种非典型抗精神病药的口腔崩解片与标准口服片剂在美国治疗精神分裂症的成本效益比较。
J Med Econ. 2012;15(3):531-47. doi: 10.3111/13696998.2012.662923. Epub 2012 Feb 21.
3
An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco.一种经济模型,用于了解在摩洛哥,与其他口服非典型抗精神病药物相比,奥氮平口腔崩解片(ODT)和奥氮平薄膜包衣片作为一组药物治疗精神分裂症的成本效益。
Ann Gen Psychiatry. 2024 Sep 18;23(1):33. doi: 10.1186/s12991-024-00516-y.
4
Cost-effectiveness of aripiprazole orally disintegrating tablets in the treatment of schizophrenia in China.阿立哌唑口崩片治疗中国精神分裂症的成本效果分析。
Expert Rev Pharmacoecon Outcomes Res. 2020 Oct;20(5):549-557. doi: 10.1080/14737167.2020.1807331. Epub 2020 Sep 23.
5
Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China.奥氮平在中国精神分裂症一线治疗中的成本效益
J Med Econ. 2019 May;22(5):439-446. doi: 10.1080/13696998.2019.1580714. Epub 2019 Mar 5.
6
Effects of orally disintegrating vs regular olanzapine tablets on body weight, eating behavior, glycemic and lipid indices, and gastrointestinal hormones: a randomized, open comparison in outpatients with bipolar depression.口腔崩解型与普通奥氮平片对体重、进食行为、血糖和血脂指标以及胃肠激素的影响:双相抑郁门诊患者的随机开放对照研究
Ann Clin Psychiatry. 2011 Aug;23(3):193-201.
7
Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets.与标准口服片剂相比,口服崩解型奥氮平在青少年中引起的体重增加较少。
Eur Psychiatry. 2007 Oct;22(7):453-4. doi: 10.1016/j.eurpsy.2007.06.004. Epub 2007 Aug 30.
8
Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial.超重慢性精神分裂症患者口服奥氮平口崩片观察到长期体重减轻。一项为期1年的开放标签前瞻性试验。
Hum Psychopharmacol. 2008 Apr;23(3):211-6. doi: 10.1002/hup.921.
9
Weight loss during therapy with olanzapine orally disintegrating tablets: two case reports.使用奥氮平口腔崩解片治疗期间体重减轻:两例病例报告。
Psychiatr Danub. 2009 Mar;21(1):72-4.
10
Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.奥氮平口腔崩解片治疗急性发病的不依从性精神分裂症患者。
Int J Neuropsychopharmacol. 2003 Jun;6(2):97-102. doi: 10.1017/S1461145703003389.

引用本文的文献

1
An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco.一种经济模型,用于了解在摩洛哥,与其他口服非典型抗精神病药物相比,奥氮平口腔崩解片(ODT)和奥氮平薄膜包衣片作为一组药物治疗精神分裂症的成本效益。
Ann Gen Psychiatry. 2024 Sep 18;23(1):33. doi: 10.1186/s12991-024-00516-y.
2
Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder.奥氮平口腔崩解片与标准口服片剂治疗精神分裂症或双相情感障碍不依从患者的临床疗效比较
Patient Prefer Adherence. 2017 Jun 6;11:1019-1025. doi: 10.2147/PPA.S124581. eCollection 2017.
3

本文引用的文献

1
Olanzapine oro-dispersible (Velotab TM ) - an alternative to depot?奥氮平口腔崩解片(再普乐 TM )——一种替代长效针剂的选择?
Int J Psychiatry Clin Pract. 2002;6(3):163-5. doi: 10.1080/136515002760276090.
2
Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia.新治疗患者中对非典型抗精神病药物治疗的依从性:一项基于人群的精神分裂症研究。
J Clin Psychiatry. 2007 Jun;68(6):818-25. doi: 10.4088/jcp.v68n0601.
3
Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study.
The Nursing Assessment of Medication Acceptance: the reliability and validity of a schizophrenia medication adherence scale.药物接受度的护理评估:精神分裂症药物依从性量表的信效度
Ther Adv Psychopharmacol. 2017 Jan;7(1):11-16. doi: 10.1177/2045125316672546. Epub 2016 Oct 6.
4
Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties.口腔崩解型奥氮平综述:有效性、患者偏好、依从性及其他特性
Patient Prefer Adherence. 2012;6:109-25. doi: 10.2147/PPA.S27344. Epub 2012 Feb 1.
5
Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study.一项多中心、随机、交叉研究比较了奥氮平口崩片与普通口服片剂在患者中的偏好。
World J Biol Psychiatry. 2010 Oct;11(7):894-903. doi: 10.3109/15622975.2010.505663.
6
Olanzapine orally disintegrating tablet: a review of efficacy and compliance.奥氮平口腔崩解片:疗效与依从性综述
CNS Neurosci Ther. 2008 Fall;14(3):203-14. doi: 10.1111/j.1755-5949.2008.00053.x.
7
Use of antipsychotics and benzodiazepines in patients with psychiatric emergencies: results of an observational trial.抗精神病药物和苯二氮䓬类药物在精神科急诊患者中的应用:一项观察性试验的结果
BMC Psychiatry. 2008 Jul 22;8:61. doi: 10.1186/1471-244X-8-61.
奥氮平口腔崩解片治疗严重精神性激越:一项观察性研究
Actas Esp Psiquiatr. 2007 Jan-Feb;35(1):47-51.
4
Clinical perspectives on atypical antipsychotics for treatment of agitation.非典型抗精神病药物治疗激越的临床观点
J Clin Psychiatry. 2006;67 Suppl 10:22-31.
5
A review of agitation in mental illness: treatment guidelines and current therapies.精神疾病中的激越综述:治疗指南与当前疗法
J Clin Psychiatry. 2006;67 Suppl 10:13-21.
6
Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.非典型抗精神病药物治疗精神分裂症和分裂情感性障碍的暴力患者。
Arch Gen Psychiatry. 2006 Jun;63(6):622-9. doi: 10.1001/archpsyc.63.6.622.
7
Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.米氮平口腔崩解片与舍曲林:一项前瞻性起效研究
J Clin Psychopharmacol. 2003 Aug;23(4):358-64. doi: 10.1097/01.jcp.0000085408.08426.05.
8
Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation.急性激越状态下初始口服奥氮平剂量快速增至每日40毫克的有效性。
J Clin Psychopharmacol. 2003 Aug;23(4):342-8. doi: 10.1097/01.jcp.0000085406.08426.a8.
9
Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.奥氮平口腔崩解片治疗急性发病的不依从性精神分裂症患者。
Int J Neuropsychopharmacol. 2003 Jun;6(2):97-102. doi: 10.1017/S1461145703003389.
10
Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients.奥氮平与传统抗精神病药物在首发精神分裂症住院患者急性治疗中的安全性和有效性比较
Prog Neuropsychopharmacol Biol Psychiatry. 2003 May;27(3):473-81. doi: 10.1016/S0278-5846(03)00035-6.